NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Detact Diagnostics

Detact Diagnostics

Private
GroningenHealthcare & Life Scienceshttps://www.detactdiagnostics.com/

Last Round

Grant

May 1, 2026

Total Funding Raised

$9.71M

Company Overview

Detact Diagnostics is a biotechnology company that develops rapid, affordable infection detection solutions using its proprietary VIPER® platform technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

point-of-care diagnosticspathogen detectionPOC testingrapid diagnostic testrapid testingnear infrared fluorescenceNIR fluorometerportable diagnostic devicehandheld diagnosticsmedical devicebiotech equipmentfood safety testinginfectious disease testingclinical diagnosticslab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Detact Diagnostics Comparables

Compare Detact Diagnostics with similar companies based on industry and business-model similarity.

Detact Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Microbiosensor Ltd
81%
Neomend
72%
Lumos Diagnostics Holdings Limited
71%

Detact Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2026
GrantOct 28, 2025
GrantNov 7, 2024
GrantOct 1, 2024
VC RoundDec 17, 2020
VC Round
Apr 19, 2017

Key People

Founding team and executive leadership

Joost Gazendam

Chief Executive Officer

Executive Team

Matt Burton

CTO IP Director

Executive Team

Hedi Koning

Chief Operating Officer

Executive Team

Detact Diagnostics Investors

Notable investors and investment history

Detact Diagnostics investors
InvestorRounds
Bill & Melinda Gates FoundationGrant
Noordelijke Ontwikkelings MaatschappijVC Round
Pacific6 EnterprisesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2024

    Received $1.7M from the Bill & Melinda Gates Foundation.

Detact Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Detact Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Detact Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersGroningen
Employee Range9
Year Founded2014
Last FundingMay 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.